Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China · Delayed Price · Currency is CNY 7.00
-0.03 (-0.43%)
Jul 18, 2025, 3:04 PM CST
SHE:002252 Revenue
Shanghai RAAS Blood Products had revenue of 2.01B CNY in the quarter ending March 31, 2025, a decrease of -2.45%. This brings the company's revenue in the last twelve months to 8.13B, up 2.12% year-over-year. In the year 2024, Shanghai RAAS Blood Products had annual revenue of 8.18B with 2.67% growth.
Revenue (ttm)
8.13B
Revenue Growth
+2.12%
P/S Ratio
5.69
Revenue / Employee
2.43M
Employees
3,350
Market Cap
46.23B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |